HERSHBERG ROBERT
Insider CIK 1274139 · NSTG Director · FATE Director · ADPT Director · RXRX Director · SBTX Director · ATAI Director · HLVX See Remarks, Director · ATAI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2026-10-06 | 2026-10-07 | 25,000 | $2.22 | $55.5K | 500,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | S Sale | 2026-10-06 | 2026-10-07 | 25,000 | $5.00 | $125.0K | 162,156 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2026-10-06 | 2026-10-07 | 25,000 | $2.22 | $55.5K | 187,156 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 404,869 | — | $0 | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 48,858 | — | $0 | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 121,968 | — | $0 | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 103,000 | — | $0 | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 62,394 | — | $0 | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 121,968 | — | — | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 103,000 | — | — | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 62,394 | — | — | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 404,869 | — | — | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 48,858 | — | — | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2026-08-18 | 2026-08-20 | 15,000 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2026-08-18 | 2026-08-20 | 15,000 | $6.32 | $94.8K | 77,347 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2026-08-18 | 2026-08-20 | 15,664 | $24.41 | $382.4K | 46,683 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2026-08-18 | 2026-08-20 | 15,000 | $24.39 | $365.9K | 62,347 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2026-08-18 | 2026-08-20 | 15,000 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2026-08-18 | 2026-08-20 | 15,664 | $24.41 | $382.4K | 46,683 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2026-08-18 | 2026-08-20 | 15,000 | $24.39 | $365.9K | 62,347 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2026-08-18 | 2026-08-20 | 15,000 | $6.32 | $94.8K | 77,347 | SEC↗ |
| ATAI AtaiBeckley Inc. | M Exercise deriv | 2026-07-07 | 2026-07-09 | 48,858 | — | $0 | 48,858 | SEC↗ |
| ATAI AtaiBeckley Inc. | M Exercise deriv | 2026-07-07 | 2026-07-09 | 51,142 | — | $0 | 404,869 | SEC↗ |
| ATAI AtaiBeckley Inc. | M Exercise | 2026-07-07 | 2026-07-09 | 48,858 | $1.35 | $66.0K | 48,858 | SEC↗ |
| ATAI AtaiBeckley Inc. | M Exercise | 2026-07-07 | 2026-07-09 | 51,142 | $1.35 | $69.0K | 100,000 | SEC↗ |
| ATAI AtaiBeckley Inc. | S Sale | 2026-07-07 | 2026-07-09 | 100,000 | $4.96 | $496.0K | 100,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2026-06-17 | 2026-06-22 | 88,424 | — | $0 | 162,156 | SEC↗ |
| ATAI AtaiBeckley Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 121,968 | — | $0 | 121,968 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2026-03-04 | 2026-03-06 | 15,625 | — | $0 | 62,347 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2025-12-10 | 2025-12-12 | 22,968 | $16.00 | $367.5K | 46,722 | SEC↗ |
| ATAI Atai Beckley N.V. | A Award deriv | 2025-11-05 | 2025-11-06 | 103,000 | — | $0 | 103,000 | SEC↗ |
| ATAI Atai Beckley N.V. | A Award deriv | 2025-11-05 | 2025-11-06 | 62,394 | — | $0 | 62,394 | SEC↗ |
| ATAI Atai Beckley N.V. | A Award deriv | 2025-11-05 | 2025-11-06 | 97,716 | — | $0 | 97,716 | SEC↗ |
| ATAI Atai Beckley N.V. | A Award deriv | 2025-11-05 | 2025-11-06 | 456,011 | — | $0 | 456,011 | SEC↗ |
| HLVX HilleVax, Inc. | U Tender | 2025-09-17 | 2025-09-17 | 1,101,498 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2025-06-18 | 2025-06-23 | 44,031 | — | $0 | 44,031 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2025-06-18 | 2025-06-23 | 22,016 | — | $0 | 73,732 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2025-03-12 | 2025-03-12 | 53,000 | $7.59 | $402.3K | 69,690 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2025-03-04 | 2025-03-06 | 23,726 | — | $0 | 23,726 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2025-03-04 | 2025-03-06 | 15,394 | — | $0 | 122,690 | SEC↗ |
| HLVX HilleVax, Inc. | S Sale | 2025-02-11 | 2025-02-12 | 11,901 | $1.76 | $20.9K | 1,101,498 | SEC↗ |
| HLVX HilleVax, Inc. | S Sale | 2025-02-04 | 2025-02-12 | 14,634 | $1.89 | $27.7K | 1,113,399 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2024-06-03 | 2024-06-05 | 26,193 | — | $0 | 26,193 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2024-06-03 | 2024-06-05 | 13,097 | — | $0 | 51,716 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2024-03-04 | 2024-03-06 | 48,044 | — | $0 | 48,044 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2024-03-04 | 2024-03-06 | 31,328 | — | $0 | 107,296 | SEC↗ |
| HLVX HilleVax, Inc. | A Award deriv | 2024-02-08 | 2024-02-12 | 226,885 | — | $0 | 226,885 | SEC↗ |
| HLVX HilleVax, Inc. | S Sale | 2024-02-08 | 2024-02-12 | 11,597 | $14.93 | $173.1K | 953,831 | SEC↗ |
| HLVX HilleVax, Inc. | A Award | 2024-02-08 | 2024-02-12 | 174,202 | — | $0 | 1,128,033 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2023-06-16 | 2023-06-21 | 25,224 | — | $0 | 25,224 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2023-06-16 | 2023-06-21 | 12,612 | — | $0 | 38,619 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2023-06-06 | 2023-06-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2023-03-06 | 2023-03-08 | 23,329 | — | $0 | 23,329 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2023-03-06 | 2023-03-08 | 14,775 | — | $0 | 75,968 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2023-02-02 | 2023-02-03 | 53,000 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2023-02-02 | 2023-02-03 | 53,000 | $0.45 | $23.9K | 61,193 | SEC↗ |
| HLVX HilleVax, Inc. | A Award deriv | 2023-02-01 | 2023-02-03 | 381,950 | — | $0 | 381,950 | SEC↗ |
| HLVX HilleVax, Inc. | A Award | 2023-02-01 | 2023-02-03 | 187,966 | — | $0 | 965,428 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2022-06-14 | 2022-06-16 | 36,290 | — | $0 | 36,290 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-06-14 | 2022-06-16 | 18,145 | — | $0 | 26,007 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2022-06-10 | 2022-06-13 | 18,000 | — | $0 | 18,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2022-06-09 | 2022-06-13 | 11,893 | — | $0 | 11,893 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2022-06-09 | 2022-06-13 | 8,650 | — | $0 | 10,659 | SEC↗ |
| FATE FATE THERAPEUTICS INC | S Sale | 2022-06-03 | 2022-06-06 | 672 | $22.75 | $15.3K | 2,009 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2022-04-18 | 2022-04-18 | 3,306 | — | $0 | 584 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2022-04-18 | 2022-04-18 | 3,306 | — | $0 | 10,716 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2022-01-26 | 2022-01-28 | 16,722 | — | $0 | 16,722 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2022-01-26 | 2022-01-28 | 6,689 | — | $0 | 8,193 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-01-03 | 2022-01-05 | 693 | — | $0 | 7,862 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-10-01 | 2021-10-05 | 572 | — | $0 | 7,169 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-07-01 | 2021-07-06 | 347 | — | $0 | 6,597 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2021-06-16 | 2021-06-17 | 3,890 | — | $0 | 3,890 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2021-06-15 | 2021-06-17 | 5,520 | — | $0 | 0 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2021-06-15 | 2021-06-17 | 5,520 | — | $0 | 7,410 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2021-06-04 | 2021-09-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2021-06-02 | 2021-06-04 | 4,334 | — | $0 | 4,334 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award | 2021-06-02 | 2021-06-04 | 2,681 | — | $0 | 2,681 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 12,500 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 525,000 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 525,000 | — | $0 | 525,000 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-22 | 6,250 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion | 2021-04-20 | 2021-04-22 | 6,250 | — | $0 | 6,250 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2021-04-16 | 2021-04-19 | 6,250 | — | $0 | 6,250 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2021-04-15 | 2021-04-19 | 144 | $14.71 | $2.1K | 7,684 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2021-04-15 | 2021-04-19 | 12,500 | — | $0 | 12,500 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-04-15 | 2021-04-19 | 118 | $74.20 | $8.8K | 1,890 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-04-15 | 2021-04-19 | 19 | $72.87 | $1.4K | 2,008 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-04-15 | 2021-04-19 | 7 | $71.75 | $502 | 2,027 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2021-04-15 | 2021-04-19 | 144 | $14.71 | $2.1K | 2,034 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2021-03-15 | 2021-03-17 | 1,500 | — | $0 | 0 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-03-15 | 2021-03-17 | 1,214 | $67.16 | $81.5K | 1,890 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-03-15 | 2021-03-17 | 282 | $66.03 | $18.6K | 3,104 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2021-03-15 | 2021-03-17 | 1,500 | $11.20 | $16.8K | 3,390 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-03-15 | 2021-03-17 | 4 | $63.58 | $254 | 3,386 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2021-03-08 | 2021-03-10 | 2,000 | — | $0 | 53,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2021-03-08 | 2021-03-10 | 2,000 | — | $0 | 53,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2021-03-08 | 2021-03-10 | 2,000 | $0.45 | $900 | 2,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-03-08 | 2021-03-10 | 2,000 | $44.56 | $89.1K | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-03-08 | 2021-03-10 | 2,000 | $44.56 | $89.1K | 1,504 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2021-03-08 | 2021-03-10 | 2,000 | $0.45 | $900 | 3,504 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2021-02-16 | 2021-02-17 | 2,000 | — | $0 | 55,000 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2021-02-16 | 2021-02-18 | 1,188 | $11.20 | $13.3K | 1,500 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2021-02-16 | 2021-02-17 | 2,000 | $0.45 | $900 | 3,504 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-02-16 | 2021-02-17 | 2,000 | $65.45 | $130.9K | 1,504 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-02-16 | 2021-02-18 | 318 | $78.40 | $24.9K | 2,760 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-02-16 | 2021-02-18 | 323 | $79.53 | $25.7K | 2,437 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-02-16 | 2021-02-18 | 163 | $82.83 | $13.5K | 1,959 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2021-02-16 | 2021-02-18 | 1,188 | $11.20 | $13.3K | 3,078 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-02-16 | 2021-02-18 | 69 | $83.93 | $5.8K | 1,890 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-02-16 | 2021-02-18 | 159 | $80.55 | $12.8K | 2,278 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-02-16 | 2021-02-18 | 156 | $81.79 | $12.8K | 2,122 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2021-02-14 | 2021-02-17 | 3,759 | — | $0 | 3,759 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award | 2021-02-14 | 2021-02-17 | 1,504 | — | $0 | 1,504 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2021-01-15 | 2021-01-19 | 1,500 | $11.20 | $16.8K | 2,688 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2021-01-15 | 2021-01-20 | 2,000 | — | $0 | 57,000 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2021-01-15 | 2021-01-19 | 1,500 | $11.20 | $16.8K | 3,390 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-01-15 | 2021-01-19 | 709 | $71.77 | $50.9K | 2,681 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-01-15 | 2021-01-19 | 410 | $72.91 | $29.9K | 2,271 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-01-15 | 2021-01-19 | 291 | $73.66 | $21.4K | 1,980 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2021-01-15 | 2021-01-19 | 90 | $74.55 | $6.7K | 1,890 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2021-01-15 | 2021-01-20 | 2,000 | $0.45 | $900 | 2,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-01-15 | 2021-01-20 | 1,378 | $66.34 | $91.4K | 622 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-01-15 | 2021-01-20 | 622 | $67.05 | $41.7K | 0 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2020-12-15 | 2020-12-16 | 1,500 | $11.20 | $16.8K | 4,188 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2020-12-15 | 2020-12-16 | 2,000 | — | $0 | 59,000 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-12-15 | 2020-12-16 | 812 | $69.88 | $56.7K | 1,890 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-12-15 | 2020-12-16 | 688 | $68.68 | $47.3K | 2,702 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2020-12-15 | 2020-12-16 | 1,500 | $11.20 | $16.8K | 3,390 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-12-15 | 2020-12-16 | 241 | $57.01 | $13.7K | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-12-15 | 2020-12-16 | 1,759 | $55.78 | $98.1K | 241 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2020-12-15 | 2020-12-16 | 2,000 | $0.45 | $900 | 2,000 | SEC↗ |
| SBTX Silverback Therapeutics, I | A Award deriv | 2020-12-03 | 2020-12-07 | 73,251 | — | $0 | 73,251 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2020-11-16 | 2020-11-18 | 1,500 | $11.20 | $16.8K | 5,688 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2020-11-16 | 2020-11-18 | 2,000 | — | $0 | 61,000 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-11-16 | 2020-11-18 | 746 | $47.03 | $35.1K | 1,890 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2020-11-16 | 2020-11-18 | 1,500 | $11.20 | $16.8K | 3,390 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-11-16 | 2020-11-18 | 754 | $46.31 | $34.9K | 2,636 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-11-16 | 2020-11-18 | 1,777 | $47.60 | $84.6K | 223 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2020-11-16 | 2020-11-18 | 2,000 | $0.45 | $900 | 2,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-11-16 | 2020-11-18 | 223 | $48.41 | $10.8K | 0 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2020-10-15 | 2020-10-16 | 1,500 | $11.20 | $16.8K | 7,188 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2020-10-15 | 2020-10-16 | 2,000 | — | $0 | 63,000 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-10-15 | 2020-10-16 | 1,023 | $39.54 | $40.4K | 1,890 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-10-15 | 2020-10-16 | 477 | $38.93 | $18.6K | 2,913 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2020-10-15 | 2020-10-16 | 1,500 | $11.20 | $16.8K | 3,390 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2020-10-15 | 2020-10-16 | 2,000 | $0.45 | $900 | 2,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-10-15 | 2020-10-16 | 2,000 | $51.51 | $103.0K | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2020-09-15 | 2020-09-16 | 2,000 | — | $0 | 65,000 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2020-09-15 | 2020-09-17 | 1,500 | $11.20 | $16.8K | 8,688 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-09-15 | 2020-09-16 | 2,000 | $42.58 | $85.2K | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2020-09-15 | 2020-09-16 | 2,000 | $0.45 | $900 | 2,000 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-09-15 | 2020-09-17 | 1,337 | $43.55 | $58.2K | 2,053 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-09-15 | 2020-09-17 | 163 | $44.20 | $7.2K | 1,890 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2020-09-15 | 2020-09-17 | 1,500 | $11.20 | $16.8K | 3,390 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2020-08-17 | 2020-08-19 | 1,500 | $11.20 | $16.8K | 10,188 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2020-08-17 | 2020-08-19 | 2,000 | — | $0 | 67,000 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-08-17 | 2020-08-19 | 414 | $37.71 | $15.6K | 2,976 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2020-08-17 | 2020-08-19 | 1,500 | $11.20 | $16.8K | 3,390 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-08-17 | 2020-08-19 | 846 | $38.44 | $32.5K | 2,130 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-08-17 | 2020-08-19 | 240 | $39.26 | $9.4K | 1,890 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2020-08-17 | 2020-08-19 | 2,000 | $0.45 | $900 | 2,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-08-17 | 2020-08-19 | 1,439 | $39.13 | $56.3K | 561 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-08-17 | 2020-08-19 | 561 | $40.04 | $22.5K | 0 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2020-07-15 | 2020-07-17 | 1,500 | $11.20 | $16.8K | 11,688 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2020-07-15 | 2020-07-17 | 2,000 | — | $0 | 69,000 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-07-15 | 2020-07-17 | 1,155 | $36.40 | $42.0K | 1,890 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-07-15 | 2020-07-17 | 345 | $35.31 | $12.2K | 3,045 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2020-07-15 | 2020-07-17 | 1,500 | $11.20 | $16.8K | 3,390 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-07-15 | 2020-07-17 | 500 | $44.58 | $22.3K | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2020-07-15 | 2020-07-17 | 2,000 | $0.45 | $900 | 2,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-07-15 | 2020-07-17 | 1,500 | $43.60 | $65.4K | 500 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2020-06-16 | 2020-06-17 | 5,520 | — | $0 | 5,520 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2020-06-15 | 2020-06-17 | 1,890 | — | $0 | 0 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2020-06-15 | 2020-06-17 | 1,500 | $7.47 | $11.2K | 13,188 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2020-06-15 | 2020-06-17 | 2,000 | — | $0 | 71,000 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2020-06-15 | 2020-06-17 | 1,890 | — | $0 | 1,890 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-06-15 | 2020-06-17 | 1,500 | $30.79 | $46.2K | 1,890 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2020-06-15 | 2020-06-17 | 1,500 | $11.20 | $16.8K | 3,390 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2020-06-15 | 2020-06-17 | 2,000 | $0.45 | $900 | 2,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-06-15 | 2020-06-17 | 1,016 | $42.59 | $43.3K | 984 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-06-15 | 2020-06-17 | 984 | $43.42 | $42.7K | 0 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise deriv | 2020-05-15 | 2020-05-18 | 10,168 | $7.47 | $76.0K | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2020-05-15 | 2020-05-18 | 2,000 | — | $0 | 73,000 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-05-15 | 2020-05-18 | 3,715 | $31.20 | $115.9K | 0 | SEC↗ |
| NSTG NanoString Technologies In | S Sale | 2020-05-15 | 2020-05-18 | 6,453 | $30.61 | $197.5K | 3,715 | SEC↗ |
| NSTG NanoString Technologies In | M Exercise | 2020-05-15 | 2020-05-18 | 10,168 | $7.47 | $76.0K | 10,168 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-05-15 | 2020-05-18 | 398 | $36.10 | $14.4K | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-05-15 | 2020-05-18 | 400 | $35.23 | $14.1K | 398 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2020-05-15 | 2020-05-18 | 2,000 | $0.45 | $900 | 2,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-05-15 | 2020-05-18 | 1,202 | $34.14 | $41.0K | 798 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2020-05-01 | 2020-05-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| FATE FATE THERAPEUTICS INC | A Award deriv | 2020-05-01 | 2020-05-05 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise deriv | 2020-04-23 | 2020-04-27 | 25,000 | — | $0 | 75,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-04-23 | 2020-04-27 | 25,000 | $29.77 | $744.3K | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | M Exercise | 2020-04-23 | 2020-04-27 | 25,000 | $0.45 | $11.3K | 25,000 | SEC↗ |
| ADPT Adaptive Biotechnologies C | A Award deriv | 2020-02-13 | 2020-02-18 | 8,888 | — | $0 | 8,888 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2019-06-18 | 2019-06-20 | 3,857 | — | $0 | 3,857 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2019-06-18 | 2019-06-20 | 1,890 | — | $0 | 1,890 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2019-03-25 | 2019-03-27 | 4,410 | — | $0 | 4,410 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2018-01-01 | 2018-01-03 | 10,168 | — | $0 | 10,168 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2017-01-01 | 2017-01-04 | 8,611 | — | $0 | 8,611 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2016-01-01 | 2016-01-05 | 7,828 | — | $0 | 7,828 | SEC↗ |
| NSTG NanoString Technologies In | A Award deriv | 2015-03-02 | 2015-03-03 | 14,688 | — | $0 | 14,688 | SEC↗ |